Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JPUS | 142.45 | -0.54 | -0.38% |
| JPMorgan Diversified Return Use Equity (JPUS) | |||
| CRMG | 7.61 | -0.13 | -1.68% |
| Leverage Shares 2X Long CRM Daily ETF (CRMG) | |||
| MDYG | 102.87 | -2.03 | -1.94% |
| State Street SPDR S&P 400 Mid Cap Growth ETF (MDYG) | |||
| YBTC | 17.35 | -0.95 | -5.17% |
| Roundhill Bitcoin Covered Call Strategy ETF (YBTC) | |||
| BIDG | 4.59 | -0.29 | -5.92% |
| Leverage Shares 2X Long BIDU Daily ETF (BIDG) | |||
Industry Biotechnology